Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review
about
sameAs
Antiplatelet agents for preventing pre-eclampsia and its complicationsPathophysiology of placentation abnormalities in pregnancy-induced hypertensionThrombophilia and pregnancyAntiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysisNew signaling routes for an old drug: lipoxin A4 might mediate heme oxygenase-1 induction by aspirin. Focus on "Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells"The public health potential of aspirinProphylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin aloneProstacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disordersPhysiologic and pathologic changes of platelets in pregnancy.Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial.Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.Low-molecular-weight heparins during pregnancyPublic health perspectives of preeclampsia in developing countries: implication for health system strengthening.Recent developments in obstetrics.Pregnancy and its management in the Philadelphia negative myeloproliferative diseases.Prioritisation of tests for the prediction of preeclampsia complications: a Delphi survey.Tests for predicting complications of pre-eclampsia: a protocol for systematic reviews.Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia.A randomised trial to evaluate the effects of low-dose aspirin in gestation and reproduction: design and baseline characteristics.Preeclampsia-eclampsiaUltrasound markers for the detection of women at risk of developing pre-eclampsia.The effects of antenatal anticoagulants (low-molecular-weight heparin and aspirin) on neonatal pulmonary vasculature in rabbits.Aspirin for Prevention of Preeclampsia.Aspirin for pre-eclampsia: beware of subgroup meta-analysis.Human chronic gonadotropin concentrations in very early pregnancy and subsequent preeclampsia.First-trimester uterine artery blood flow and birth weight.Influence of perinatal low-dose acetylsalicylic acid therapy on fetal hemodynamics evaluated by determining the acceleration-time/ejection-time ratio in the ductus arteriosus.A Bayesian growth mixture model to examine maternal hypertension and birth outcomes.sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).2013 ESH/ESC Guidelines for the management of arterial hypertensionStrategies to prevent eclampsia in a developing country: I. Reorganization of maternity servicesCan heparin prevent adverse pregnancy outcome?
P2860
Q24245285-B626AA73-BFFA-47AB-A0A5-D187E8627679Q24649934-6220A7D3-A183-4E88-8EEC-87EAEE857B95Q24801115-24302556-C1C0-4397-AB46-E1645A21F0DAQ24806475-358D58D8-7EEE-47DE-84C3-7094F0AA3227Q28187259-A5E1A5A5-1D1D-488B-8CC0-1D9DB8FFF5EEQ28194137-6FD2B626-E26E-48A5-A871-344A78EB0A19Q28199764-1FE8B39E-D19C-495D-8A1B-C860F4563989Q28210333-F8341087-B4A6-4904-B931-C99678F83F63Q33392053-898E8899-CD64-416B-BE84-05AADDB16C83Q33441799-1255E23F-83D3-4A7D-9017-6E360B859505Q34274204-3B35C796-218D-47E6-B1AA-AFBAD0D3DD0BQ34299778-3DA11906-2F12-4335-AAE8-50952E082971Q34654165-5ADC555C-47DF-4733-8EA4-253655C6D835Q34919890-AF987A94-E815-4047-8D71-7B4F9E84820DQ35217175-A6184BB3-3FBC-4865-9C32-FA99AAD6A647Q36103178-ECB76F1A-667E-4B27-BF1D-301593750849Q36799659-A491DF34-726C-42C9-A2CD-5B9DF021DA73Q36908183-AAA9353B-4972-4ADC-B5FC-1110AAE3C66FQ37083055-19D634F0-F3E4-497A-BED5-754AB7D5496FQ37292044-AB3C6F8A-02F0-4AAC-99D1-A5B8C19F8D2EQ37597855-53733DEA-226E-42F4-9941-91BC27513504Q37965734-F17989C6-4A0E-4A0E-8D21-78DC639DAB56Q43227978-79C3F260-D74E-4329-B3DC-5D7D46ADFE4DQ43281151-941973BD-016B-44F9-AB63-00CE8560430EQ44029219-A9783D50-075E-43B3-9746-4293B4B141D3Q47211715-9C7FB9E3-548F-46F8-BDD6-1BA398FD9284Q47440334-9A1B2440-4329-4ED2-82CB-8B948B78B075Q48233874-FCEAEAAD-395E-4A92-B225-64D9B900EB3BQ51548799-2EF7DC60-65B8-40DD-A86C-335E2213419DQ54161406-40ACE320-6E2B-42DE-92B3-D73C483639D5Q56970511-0B1CFEA6-98BA-4716-BD04-79FF5210A88AQ57385971-BC99D779-A850-4B0C-9DBE-7CC728C3DD01Q58778341-5E1C8D6E-720A-4D4D-91A4-817D9EBE9F14
P2860
Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antiplatelet drugs for prevent ...... onsequences: systematic review
@ast
Antiplatelet drugs for prevent ...... onsequences: systematic review
@en
Antiplatelet drugs for prevent ...... onsequences: systematic review
@nl
type
label
Antiplatelet drugs for prevent ...... onsequences: systematic review
@ast
Antiplatelet drugs for prevent ...... onsequences: systematic review
@en
Antiplatelet drugs for prevent ...... onsequences: systematic review
@nl
prefLabel
Antiplatelet drugs for prevent ...... onsequences: systematic review
@ast
Antiplatelet drugs for prevent ...... onsequences: systematic review
@en
Antiplatelet drugs for prevent ...... onsequences: systematic review
@nl
P2093
P2860
P356
P1433
P1476
Antiplatelet drugs for prevent ...... onsequences: systematic review
@en
P2093
D Henderson-Smart
P2860
P304
P356
10.1136/BMJ.322.7282.329
P407
P50
P577
2001-02-10T00:00:00Z